Zhibo Han

Zhibo Han


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2024 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
LLLimin Liu
Limin Liu
YYYulin Ye
Yulin Ye
RLRui Lin
Rui Lin
TLTianyu Liu
Tianyu Liu
SWSinan Wang
Sinan Wang
XCXiaocang Cao
Xiaocang Cao
Ferroptosis is a newly discovered form of cell death that is featured in a wide range of diseases. Exosome therapy is a promising therapeutic option that has attracted much attention due to its low immunogenicity, low toxicity, and ability to penetrate biological barriers. In addition, emerging evidence indicates that exosomes possess the ability to modulate the progression of diverse diseases by regulating ferroptosis in damaged cells. Hence, the mechanism by which cell-derived and noncellular-derived exosomes target ferroptosis in different diseases through the system Xc−/GSH/GPX4 axis, NAD(P)H/FSP1/CoQ10 axis, iron metabolism pathway and lipid metabolism pathway associated with ferroptosis, as well as its applications in liver disease, neurological diseases, lung injury, heart injury, cancer and other diseases, are summarized here. Additionally, the role of exosome-regulated ferroptosis as an emerging repair mechanism for damaged tissues and cells is also discussed, and this is expected to be a promising treatment direction for various diseases in the future.

9 November 2022 in International Immunopharmacology
Verified
Journal Article
Closed access
HYHao Yu
Hao Yu
YFYing Feng
Ying Feng
WDWenjing Du
Wenjing Du
MZMeng Zhao
Meng Zhao
HJHonghong Jia
Honghong Jia
ZHZhibo Han
Zhibo Han